These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 9004052
1. Electrocardiographic effects of fluoxetine and doxepin in patients with major depressive disorder. Baker B, Dorian P, Sandor P, Shapiro C, Schell C, Mitchell J, Irvine MJ. J Clin Psychopharmacol; 1997 Feb; 17(1):15-21. PubMed ID: 9004052 [Abstract] [Full Text] [Related]
6. Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression. Akhondzadeh S, Faraji H, Sadeghi M, Afkham K, Fakhrzadeh H, Kamalipour A. J Clin Pharm Ther; 2003 Oct; 28(5):379-84. PubMed ID: 14632962 [Abstract] [Full Text] [Related]
7. A double-blind parallel study to compare fluoxetine with doxepin in the treatment of major depressive disorders. Tamminen TT, Lehtinen VV. Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():51-6. PubMed ID: 2783699 [No Abstract] [Full Text] [Related]
13. Predictors of response to amine-specific antidepressants. Burns RA, Lock T, Edwards DR, Katona CL, Harrison DA, Robertson MM, Nairac B, Abou-Saleh MT. J Affect Disord; 1995 Dec 13; 35(3):97-106. PubMed ID: 8749837 [Abstract] [Full Text] [Related]
14. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ, Comparative Efficacy Antidepressants Study Group. CNS Drugs; 2005 Dec 13; 19(2):137-46. PubMed ID: 15697327 [Abstract] [Full Text] [Related]
15. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. Marttila M, Jääskeläinen J, Järvi R, Romanov M, Miettinen E, Sorri P, Ahlfors U, Zivkov M. Eur Neuropsychopharmacol; 1995 Dec 13; 5(4):441-6. PubMed ID: 8998395 [Abstract] [Full Text] [Related]
16. A double-blind comparison of moclobemide and doxepin in depressed general practice patients. Lingjaerde O, Jørgensen J, Støren R, Thomle S, Wendt Raeder L, Ruud LE, Schetelig E, Sveaas HK, Leivestad O. Acta Psychiatr Scand; 1995 Aug 13; 92(2):125-31. PubMed ID: 7572258 [Abstract] [Full Text] [Related]
17. A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation. Mansbach RS, Ludington E, Rogowski R, Kittrelle JP, Jochelson P. Clin Ther; 2011 Jul 13; 33(7):851-62. PubMed ID: 21722958 [Abstract] [Full Text] [Related]
18. Compliance in depressed patients treated with fluoxetine or amitriptyline. Belgian Compliance Study Group. Demyttenaere K, Van Ganse E, Gregoire J, Gaens E, Mesters P. Int Clin Psychopharmacol; 1998 Jan 13; 13(1):11-7. PubMed ID: 9988362 [Abstract] [Full Text] [Related]
19. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration]. Bonin B, Bertschy G, Baumann P, Francois T, Vandel P, Vandel S, Sechter D, Bizouard P. Encephale; 1996 Jan 13; 22(3):221-7. PubMed ID: 8767051 [Abstract] [Full Text] [Related]
20. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline. Marchesi C, Ceccherininelli A, Rossi A, Maggini C. Pharmacopsychiatry; 1998 Nov 13; 31(6):216-21. PubMed ID: 9930635 [Abstract] [Full Text] [Related] Page: [Next] [New Search]